Lux Capital's Life Science Portfolio

EGenesis is a gene editing and genome engineering company developing human-compatible engineered organs to treat diseases.

Anagenex is a seed stage biotechnology company building a novel platform for drug discovery focusing on difficult targets.

H1 is on a mission to connect the world to the right doctor

A-Alpha Bio uses synthetic biology and machine learning to measure, discover, predict, and engineer protein-protein interactions.

Octant Bio is a developer of synthetic technology used to improve health and treat disease.

Reinventing drug development from the ground up to make safe, effective oligonucleotide-based medicines possible on demand.

Atavistik Bio is a biotechnology company that develops precision allosteric small molecules aimed at treating metabolic diseases and cancer.

Eikon Therapeutics is a biopharmaceutical company that develops live-cell resolution microscopy and engineering for drug discovery.

Atrandi Biosciences is a Lithuanian biotech startup that aims to commercialize droplet microfluidics technology.

Bluenote Health operates as an AI platform for life sciences.

Cromatic is building software to help life-sciences companies outsource R&D.

Gandeeva’s proprietary platform provides a rational, cryo-EM- and AI-driven approach for the design of potent molecular glues.

Paradigm creates a platform that allow all patients to participate in clinical trials while also enhancing trial efficiency.

Kingdom creates and sells natural functional ingredients that actually work.

Resilience is a biomanufacturing company that provides access to complex medicines and protects biopharmaceutical supply chains.

Authorea is a provider of a collaborative platform that is designed to read, write, discuss, and publish research.